GlassScriptPhysician profile
Stacy Ann Messersmith
NPI 1689161598
$743.73
in general payments reported to CMS, 2019-2025
16 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.36 · 2022: $18.92 · 2023: $193 · 2024: $217 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $164.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $138.38 | 2023-2025 | |
| Astellas Pharma US INC | $69.18 | 2024 | Veozah |
| Amgen INC. | $63.61 | 2021-2025 | Prolia, Evenity |
| Lilly USA, LLC | $52.43 | 2022-2025 | Mounjaro |
| Janssen Pharmaceuticals, INC | $39.29 | 2024 | Spravato |
| Novo Nordisk INC | $37.75 | 2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $24.81 | 2023 | Freestyle Libre |
| Mylan Specialty L.P. | $24.80 | 2024 | Yupelri |
| Edwards Lifesciences Corporation | $23.90 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Glaxosmithkline, LLC. | $22.43 | 2023 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.68 | 2025 | |
| Idorsia Pharmaceuticals US INC | $17.89 | 2023 | Quviviq |
| Adlon Therapeutics L.P. | $16.26 | 2021 | |
| Merck Sharp & Dohme LLC | $14.94 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $14.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Messersmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.